[1] 文雪刚, 毛青松, 龚建平. 肝硬化脾切除术后门静脉血栓形成的预防研究进展[J]. 中国现代普通外科进展,2023,26(3):242-244. [2] 李丽昕, 李志杰, 白瑛, 等. 肝移植患者术后门静脉血栓发生病因及预后分析[J]. 肝脏,2021,26(9):1016-1018,1051. [3] 王宇威, 丁惠国. 肝硬化门静脉血栓防治的新靶点[J]. 中华肝脏病杂志,2024,32(6):484-488. [4] 冯雨薇, 张建军, 刘黎明, 等. 张建军教授重用水蛭辨治肝硬化门静脉血栓经验[J]. 中西医结合肝病杂志,2024,34(6):553-555. [5] 史海涛, 鲁晓岚. 门静脉血栓及肝动脉-门静脉瘘诊治再认识[J]. 实用肝脏病杂志,2023,26(2):160-163. [6] 杨莹, 石彭宇, 张曼曼. 肝硬化门静脉高压合并门静脉血栓行TIPS治疗临床分析[J]. 中国现代普通外科进展,2023,26(3):218-221. [7] 李玉军, 吴堡. 门静脉血栓形成的影像学表现及临床意义[J]. 血栓与止血学,2022,28(3):440-441. [8] 吴大海, 刘其林, 卢杰夫, 等. 乙型肝炎肝硬化并发门静脉血栓形成患者中性粒细胞胞外陷阱标志物变化[J]. 实用肝脏病杂志,2024,27(3):394-397. [9] Ghamar Talepoor A, Doroudchi M. Immunosenescence in atherosclerosis: a role for chronic viral infections[J]. Front Immunol, 2022, 13: 945016. [10] Bajwa R K, Kleb C, Faisal M S, et al. Thromboelastography characteristics in critically ill patients with liver disease[J]. Eur J Gastroenterol Hepatol, 2024, 36(2): 190-196. [11] Xu X, Jin J, Liu Y, et al. Analysis of related factors of portal vein thrombosis in liver cirrhosis[J]. BMC Gastroenterol, 2023, 23(1): 26. [12] Bedreli S, Manka P, Buechter M, et al. No differences in rotational thromboelastometry measurements between portal and peripheral circulation in cirrhotic patients undergoing TIPS[J]. J Pers Med, 2023, 13(3): 424. [13] Forgács R, Bokrétás G P, Monori Z, et al. Thromboelastometry-guided individualized fibrinolytic treatment for COVID-19-associated severe coagulopathy complicated by portal vein thrombosis: a case report[J]. Biomedicines, 2023, 11(9): 2463. [14] 杨博, 杨长青. 门静脉血栓形成基础与临床诊治探索[J]. 中华肝脏病杂志,2022,30(12):1292-1297. [15] 王慧珊, 房晔, 叶丝陶, 等. 肝硬化胃静脉曲张合并门静脉血栓患者内镜下组织胶注射治疗后早期抗凝的出血风险评估[J]. 中国临床医学,2024,31(3):361-366. [16] 韩建波, 丁永斌, 束青华, 等. 促抗凝失平衡与肝硬化门静脉高压症脾切断流术后门静脉血栓形成的关系[J]. 肝胆胰外科杂志,2023,35(4):225-229. [17] 丁靖诺, 赵卫峰. 肝硬化门静脉血栓形成危险因素及临床特征分析[J]. 中国肝脏病杂志(电子版),2022,14(4):48-54. [18] Jiang S, Ai Y, Ni L, et al. Platelet-derived TGF-β1 is related to portal vein thrombosis in cirrhosis by promoting hypercoagulability and endothelial dysfunction[J]. Front Cardiovasc Med, 2022, 9: 938397. [19] Huang J, Liu H. Portal venous blood flow velocity is a factor associated with portal venous thrombosis after partial splenic artery embolization in hepatic cirrhosis patients[J]. Ann Med Surg (Lond), 2024, 86(2): 650-654. [20] Chen M, Han J B, Zhang J K, et al. Nomogram for predicting postoperative portal venous systemic thrombosis in patients with cirrhosis undergoing splenectomy and esophagogastric devascularization[J]. Can J Gastroenterol Hepatol, 2022, 2022(1): 8084431. [21] Gao H, Sun B, Li X, et al. Risk factors for portal vein system thrombosis after partial splenic embolisation in cirrhotic patients with hypersplenism[J]. Clin Radiol, 2023, 78(12): 919-927. |